Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma

BACKGROUND: Immunotherapy is an ideal treatment modality to specifically target the diffusely infiltrative tumor cells of malignant gliomas while sparing the normal brain parenchyma. However, progress in the development of these therapies for glioblastoma has been slow due to the lack of immunogenic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Everson, Richard G., Antonios, Joseph P., Lisiero, Dominique N., Soto, Horacio, Scharnweber, Rudi, Garrett, Matthew C., Yong, William H., Li, Ning, Li, Gang, Kruse, Carol A., Liau, Linda M., Prins, Robert M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2016
Materias:
Basic and Translational Investigations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4767237/
https://ncbi.nlm.nih.gov/pubmed/26330563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nov153
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares